Navigation Links
Helix BioPharma Announces Q2 2009 Financial Results
Date:3/16/2009

Basic (0.08) (0.04) (0.13) (0.08) Diluted (0.08) (0.04) (0.13) (0.08) Consolidated Statements of Cash Flows for the three and six month periods ended January 31, 2009 and 2008 ($ thousands) Three months Six months ended January 31 ended January 31 2009 2008 2009 2008 Cash provided by (used in): Loss for the period (4,252) (1,526) (6,573) (3,170) Items not involving cash: Amortization of capital assets 63 63 127 129 Amortization of intangibles 3 3 6 10 Stock-based compensation 631 12 631 24 Foreign exchange loss (18) (153) 132 (45) (3,573) (1,601) (5,677) (3,052) Change in non-cash working capital 317 528 803 336 Operating activities (3,256) (1,073) (4,874) (2,716) Financing activities - 14,614 9,659 14,614 Investing activities (37) (9) (74) (59) Effect of exchange rate changes on cash 18 153 (132) 45 Increase in cash (3,275) 13,685 4,579 11,884 Cash: Beginning of the period 26,911 9,578 19,057 11,379 End of the period 23,636 23,263 23,636 23,263

The Company's unaudited interim consolidated financial statements and management's discussion and analysis of financial condition and results of operations will be filed today with Canadian secu
'/>"/>

SOURCE Helix BioPharma Corp.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
2. Helix BioPharma Chairman resigns
3. Helix BioPharma Corp. announces fiscal 2007 results
4. Helix BioPharma Corp. announces management changes
5. Helix BioPharma announces $16.9 million private placement of common shares
6. Helix BioPharma announces Q1 2008 financial results
7. Helix BioPharma closes $16.9 million private placement of common shares
8. Helix BioPharma Corp. contracts KBI Biopharma to develop an L-DOS47 clinical packaging format
9. Helix BioPharma shareholders vote in favour of management
10. Helix BioPharma reports Q2 2008 highlights, financial results
11. W. Thomas Hodgson appointed to board of Helix BioPharma Corp.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...v.25/PRNewswire/--Reportlinker.comannouncesthatane..., BrazilBioethanolMarketAnalysisandForecaststo2...razil-Bioethanol-Market-Analysis-and-Forecasts-to-...Forecaststo2013 ,, Summary ,, Thereportpro...anolmarketandtheBrazilbioethanolmarketinparticular...
(Date:11/24/2009)... The New York investment bank KTA Capital,s...greed an AU$6.7 mil convertible note private place...te placement was arranged by KTA Capital as Neuren... New York (PRWEB) November 23, 2...A Capital, LLC ("KTA Capital") has annou...
(Date:11/24/2009)... Health care employment grew by 29,000 jo...to show consistent growth during the U.S. recessio... in trouble, and health systems are coming closer ...ad of just administrators. , ...yment continued growing in October despite the she...
(Date:11/24/2009)...v.24/PRNewswire/--BlueMarbleEnergyCorp.announcedto...ority(OPDA)wererecentlyawarded$2millionbyWashingto...inaprivate/publicpartnershiptoconstructthestate,sf...,WA. ,, "Thisinvestmentwillsignificantlyspeedth...stoLincolnCounty,"saidBlueMarbleEnergyCEOKellyOgil...
Breaking Biology Technology:Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2
...or 2008, SAN DIEGO, May 7 Volcano Corporation (N... of intravascular ultrasound,(IVUS), functional me...CT),products designed to enhance the diagnosis and...ease, today reported results for the first quarter... 2008, Volcano reported revenues of,$36.6 million,...
...onal Validation Data for Its MISSION(R) ... 7 Sigma-Aldrich(TM) (Nasdaq:,SIAL) and the secon...ed,functional validation of the Consortium,s colle...entiviral-based shRNA vector constructs.,Currently...unctional,validation process. Validated clones cov...
...g, Inc., the parent,company of VWR International, ...ill hold a conference call on Monday, May 19th to ...o: John M. Ballbach, Chairman, President and CE...esident & Chief Financial Officer, When:... Time (ET), How: Interested parties may partic...
Other Biology Technology:Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent 2Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent 3Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent 4Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent 5Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent 6Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent 7Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent 8Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent 9Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent 10Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent 11Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent 12Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent 13Sigma-Aldrich Joins Phase 2 of The RNAi Consortium to Validate shRNA Libraries 2Sigma-Aldrich Joins Phase 2 of The RNAi Consortium to Validate shRNA Libraries 3VWR Funding, Inc. to Hold First Quarter 2008 Financial Results Conference Call 2
(Date:11/24/2009)... Cambridge, Md. (November 24, 2009) New research ...ic river ecosystems reveals predictable temporal p...e communities as markers for monitoring climate ch...is week in the Proceedings of the National Academ... communities in the six rivers shifted synchronous...
(Date:11/23/2009)... CINCINNATINew research presents strong evidence t...e to both outdoor traffic-related pollution and in...s than one or the other exposure alone. , Envi...incinnati (UC) College of Medicine have shown that...elated particles and indoor endotoxin during early...
(Date:11/23/2009)..., Cambridge, Mass. November 23, 2009 Applied ...ntain lily ( Hosta lancifolia ), a characteristic ...osely packed ripples along the edges. The simple c...n resulting from bending during differential growt..., stretching foam ribbons. , Haiyi Liang, a post...
Breaking Biology News(10 mins):Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2The cause behind the characteristic shape of a long leaf revealed 2Helix BioPharma Closes Private Placement 13918 1Helix BioPharma Closes Private Placement 13918 2Helix BioPharma Closes Private Placement 13918 3Immucor to Present at Upcoming Investor Conferences 56489 1FDA pharmaceutical import alert 56486 1
...g the approximately 23,000 genes found in human DN... as few as 50 to 100 that have no counterparts in ...he primate family known as hominoids, and there ma...distinctive contributions these genes likely make ...ey play. Now scientists at Washington University S...
...earchers have believed women choose partners based...ew study from The University of Texas at Austin re...r own attractiveness. , David Buss, psychology re...ings in Attractive Women Want it All: Good Genes, ...otional Commitment in this months Evolutionary Psy...
...08 On the evening of April 17th, in Philadelphia,...ting science and the spirit of discovery, nine ind...dals and two will be presented with prestigious Bo...a precursor to the Nobel Prize, are awarded for ou...tively impacted and enhanced the quality of human ...
Other Biology News:First study hints at insights to come from genes unique to humans 2First study hints at insights to come from genes unique to humans 3Do attractive women want it all? 2Science and technology take center stage this election year 2Science and technology take center stage this election year 3Science and technology take center stage this election year 4Science and technology take center stage this election year 5Science and technology take center stage this election year 6
Mouse Anti-Human XPC Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Rabbit Anti-Lck, phospho (Tyr192) Polyclonal Antibody, Unconjugated from Abcam
Anti-7H6 Antigen (tight-junction associated protein antigen) Monoclonal Antibody, Unconjugated, Clone 7H6 from Cell Sciences
Goat Anti-Ephrin B2 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: